<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37407214</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1554-6179</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical medicine &amp; research</Title><ISOAbbreviation>Clin Med Res</ISOAbbreviation></Journal><ArticleTitle>A Cross-Sectional Study of the Physical and Mental Well-Being of Long COVID Patients in Aruba.</ArticleTitle><Pagination><StartPage>69</StartPage><EndPage>78</EndPage><MedlinePgn>69-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3121/cmr.2023.1821</ELocationID><Abstract><AbstractText><b>Objective:</b> To investigate the pattern and prevalence of persistent symptoms of Post-COVID-19 Syndrome (PCS) at 3, 6, 9, and 18 months after discharge. Associated risk factors were further examined to potentially explain the persistence of these symptoms.<b>Design and Setting:</b> A cross-sectional cohort study was conducted at the primary health care facility of Aruba, Dr. Horacio E. Oduber Hospital (HOH).<b>Participants:</b> Inclusion criteria were adults hospitalized at HOH for at least one night between March and July 2021 and laboratory-confirmed COVID-19 diagnosis. Exclusion criteria were deceased before the follow-up, not able to mobilize before or after discharge, living outside of Aruba or in nursing homes, and patients with psychosis, dementia, or hospitalized due to unrelated diseases.<b>Methods:</b> Eligible and willing participants completed a 20-question survey: a self-reported symptoms questionnaire about symptoms during and after COVID-19 infection, level of dyspnea measurement (mMRC-scale), quality of life measurement (EQ-5D-5E with EuroQoL VAS), and mental well-being (WHO-5). Hospitalization related data were gathered via retrospective analysis of patient records. Chi-square test, logistic regression, and ANOVA analyses were conducted; <i>P</i>&lt;0.05 was chosen as level of statistical significance for all analyses.<b>Results:</b> In total, 222 (34.5%) patients were eligible, consenting, and completed the survey. Most participants were interviewed a year or more after their initial COVID-19 infection. Fatigue (37.8%), new-onset dyspnea (38.7%), hair loss (20.3%), and muscle pain (18.0%) were the most frequently reported symptoms at any time post COVID-19 infection. Female participants were found more likely to experience fatigue (<i>P</i>&lt;0.05, OR 2.135, 95% CI 1.154-3.949) and new-onset dyspnea (<i>P</i>&lt;0.05, OR 2.026 95% CI 1.093-3.756) after initial infection. Participants with one or more respiratory comorbidity were more likely to experience new-onset dyspnea (<i>P</i>&lt;0.05, OR 2.681, 95% CI 1.223-5.873). None of the predictor variables was associated with cognitive impairment.<b>Conclusion:</b> This study identified female sex and respiratory comorbidity as crucial risk factors for PCS. Females were also found to have significantly lower health scores. Female participants were more likely to experience fatigue and dyspnea after COVID-19 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Marshfield Clinic Health System.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duwel</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Faculty of Health and Life Sciences, Maastricht University, Maastricht, Limburg, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonology, Horacio E. Oduber Hospital, Oranjestad, Aruba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Kort</LastName><ForeName>Jaclyn M L</ForeName><Initials>JML</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Horacio E. Oduber Hospital, Oranjestad, Aruba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Caroline M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Horacio E. Oduber Hospital, Oranjestad, Aruba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kock</LastName><ForeName>Sel&#xe8;ne M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Horacio E. Oduber Hospital, Oranjestad, Aruba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tromp</LastName><ForeName>Garreth G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Policy Development Department, Horacio E. Oduber Hospital, Oranjestad, Aruba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busari</LastName><ForeName>Jamiu O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Educational Development and Research, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands Jamiu.Busari@maastrichtuniversity.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Horacio Oduber Hospital, Oranjestad, Aruba.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Med Res</MedlineTA><NlmUniqueID>101175887</NlmUniqueID><ISSNLinking>1539-4182</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073076" MajorTopicYN="N" Type="Geographic">Aruba</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID Syndrome</Keyword></KeywordList><CoiStatement>Disclosure: The authors have no conflicts of interest or financial support related to this work to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37407214</ArticleId><ArticleId IdType="pmc">PMC10321723</ArticleId><ArticleId IdType="doi">10.3121/cmr.2023.1821</ArticleId><ArticleId IdType="pii">cmr.2023.1821</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232. doi:10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e107. doi:10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E.. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi:10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakhamuri SM, Jankie S, Pinto Pereira LM.. Calling on Latin America and the Caribbean countries to recognise the disability from long COVID. Lancet Reg Health Am. 2022;15:100362. doi:10.1016/j.lana.2022.100362</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100362</ArticleId><ArticleId IdType="pmc">PMC9412073</ArticleId><ArticleId IdType="pubmed">36043156</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Moreno CA, Pineda J, Bare&#xf1;o A, Espitia R, Rengifo P.. Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care? Travel Med Infect Dis. 2023;51:102492. doi:10.1016/j.tmaid.2022.102492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2022.102492</ArticleId><ArticleId IdType="pmc">PMC9640373</ArticleId><ArticleId IdType="pubmed">36368518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi:10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. ; TLC Study Group . Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428-442. doi:10.1177/01410768211032850. Medline</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ.. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi:10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-754. doi:10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler DA, Wells CK.. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580-586. doi:10.1378/chest.93.3.580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.93.3.580</ArticleId><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng YS, Kohlmann T, Janssen MF, Buchholz I.. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021;30(3):647-673. doi:10.1007/s11136-020-02688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-020-02688-y</ArticleId><ArticleId IdType="pmc">PMC7952346</ArticleId><ArticleId IdType="pubmed">33284428</ArticleId></ArticleIdList></Reference><Reference><Citation>Topp CW, &#xd8;stergaard SD, S&#xf8;ndergaard S, Bech P.. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167-176. doi:10.1159/000376585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000376585</ArticleId><ArticleId IdType="pubmed">25831962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastola A, Nepal R, Shrestha B, et al. . Persistent Symptoms in Post-COVID-19 Patients Attending Follow-Up OPD at Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal. Trop Med Infect Dis. 2021;6(3):113. doi:10.3390/tropicalmed6030113</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed6030113</ArticleId><ArticleId IdType="pmc">PMC8293320</ArticleId><ArticleId IdType="pubmed">34203115</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Welson NN.. Pathophysiology of Post-COVID syndromes: a new perspective. Virol J. 2022;19(1):158. doi:10.1186/s12985-022-01891-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01891-2</ArticleId><ArticleId IdType="pmc">PMC9548310</ArticleId><ArticleId IdType="pubmed">36210445</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L.. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539-548. doi:10.1007/s10654-022-00847-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, et al. . Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615. doi:10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz MM, Arias &#xc1;, Mata-V&#xe1;zquez E, et al. . Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge. J Clin Med. 2021;10(13):2945. doi:10.3390/jcm10132945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. . Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis. 2022;74(7):1191-1198. doi:10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. doi:10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Stormorken E, Jason LA, Kirkevold M.. Factors impacting the illness trajectory of post-infectious fatigue syndrome: a qualitative study of adults&#x2019; experiences. BMC Public Health. 2017;17(1):952. doi:10.1186/s12889-017-4968-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-017-4968-2</ArticleId><ArticleId IdType="pmc">PMC5729235</ArticleId><ArticleId IdType="pubmed">29237442</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, et al. . Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect Dis. 2021;8(10):ofab440. doi:10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ.. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas). 2021;57(5):418. doi:10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda VP, Vuppu S, Mishra T, et al. . Recent review of COVID-19 management: diagnosis, treatment and vaccination. Pharmacol Rep. 2022;74(6):1120-1148. doi:10.1007/s43440-022-00425-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-022-00425-5</ArticleId><ArticleId IdType="pmc">PMC9549062</ArticleId><ArticleId IdType="pubmed">36214969</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, et al. . Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. doi:10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko ZO, Yu T, Mullapudi SK, et al. . Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. Preprint. medRxiv. 2022;2022.08.08.22278543. doi:10.1101/2022.08.08.22278543</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.08.22278543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, et al. . Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study [published correction appears in Nat Commun. 2022 Nov 1;13(1):6540]. Nat Commun. 2022;13(1):5663. doi:10.1038/s41467-022-33415-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, DePerrior SE, Ahmad Q, Dodani S.. Gender-based disparities in COVID-19 patient outcomes. J Investig Med. 2021;69(4):814-818. doi:10.1136/jim-2020-001641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2020-001641</ArticleId><ArticleId IdType="pubmed">33712520</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ttiker P, Stefano GB, Weissenberger S, et al. . HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae. Neuropsychiatr Dis Treat. 2022;18:2229-2237. doi:10.2147/NDT.S382308</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S382308</ArticleId><ArticleId IdType="pmc">PMC9548297</ArticleId><ArticleId IdType="pubmed">36221293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonif&#xe1;cio LP, Csizmar VNF, Barbosa-J&#xfa;nior F, et al. . Long-Term Symptoms among COVID-19 Survivors in Prospective Cohort Study, Brazil. Emerg Infect Dis. 2022;28(3):730-733. doi:10.3201/eid2803.212020</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2803.212020</ArticleId><ArticleId IdType="pmc">PMC8888217</ArticleId><ArticleId IdType="pubmed">35133956</ArticleId></ArticleIdList></Reference><Reference><Citation>Magesh S, John D, Li WT, et al. . Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status: A Systematic-Review and Meta-analysis [published correction appears in JAMA Netw Open. 2021 Dec 1;4(12):e2144237] [published correction appears in JAMA Netw Open. 2022 Feb 1;5(2):e222170]. JAMA Netw Open. 2021;4(11):e2134147. doi:10.1001/jamanetworkopen.2021.34147</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.34147</ArticleId><ArticleId IdType="pmc">PMC8586903</ArticleId><ArticleId IdType="pubmed">34762110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>